Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

First- and Second-Generation Antipsychotics for Children and Young Adults

Slide: 29 of 43

Summary of Comparative Effectiveness Results (2 of 2)

In within-class comparisons of second-generation antipsychotics with each other for pediatric use, olanzapine is not statistically different from risperidone or clozapine for treating schizophrenia, as assessed by clinical global impressions and positive and negative symptoms. The strength of evidence in support of this finding is low.